keyboard_arrow_up

Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

Reportstack has announced a new market research publication on Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective which covers several technologies, epigenetic targets, and market outlook. The first part of this report covers necessary background information, mostly pertaining to epigenetic targets, and the reasons they are being investigated. Several companies have kindly disclosed several strategies, methods, and techniques that they use for either target identification or technology development. 
Report Features Include:  
 
Survey data results  
Company background information 
Interviews with CEOs, CSOs, and Expert Scientists  
Specific pharmaceutical/biopharmaceutical companies and their strategies 
 
In this report, several targets and their properties are discussed including histone methyltransferases, histone demethylases, and bromodomains. A list of known histone modifications is also present. This includes companies (if applicable), targets being studied, diseases they are associated with, and their clinical developmental status. The report includes specific pharmaceutical/biopharmaceutical companies and their strategies behind their target identifications and validation. These companies include Constellation Pharmaceuticals, Epizyme Inc., and EpiTherapeutics. The report covers technologies and assays available from the following biotechnology companies: Active Motif (including ChIP technology and a current list of validated antibodies), Cayman Chemical, and Reaction Biology. 
Areas covered for this report include: 
Company backgrounds 
Areas of interest 
Challenges encountered 
Competitive advantages 
Partnerships 
 
Additionally, these sections also include interviews with CEOs, CSOs, and expert scientists of the participating companies. 

The report also gives insight into the epigenetics community. Insight Pharma Reports polled a survey which had more than 150 responses. Specific areas highlighted are targets under investigation, market outlook, and how partnerships with external organizations have advanced the industry. 

To view the table of contents and know more details please visit Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective report.